IP Library Granted Patent US 7,544,301
Granted Patent B2
US 7,544,301 · App. 10/921,677 · Granted Jun 9, 2009

Citrate-based dialysate chemical formulations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,301
App. No.
10/921,677
Granted
Jun 9, 2009
Kind
B2
Abstract

The present invention constitutes dialysate formulations that are suitable for use in preparing dialysate solutions for use in batch and/or proportioning systems and for improving dialysis efficiency by reducing or preventing clotting of the dialysis flow paths. The dialysate chemical formulations for one batch of dialysate comprise an acid concentrate stored in a first vessel, and a citrate-containing bicarbonate concentrate stored in a second vessel. The contents of the first and second vessels are emptied into a dialysate preparation tank and mixed with water to form a batch quantity of dialysate solution. Alternately, a dry acid and/or a dry citrate-containing base concentrates are dissolved separately in measured quantities of water to form liquid concentrates which are then used in conjunction with a proportioning machine to generate on-line a final dialysis solution stream.

Claims (56)

1. A method of making a dialysate and circulating the dialysate comprising:

(a) providing a dialysis apparatus comprising a conductivity sensor for measuring conductivity of a solution and a dialyzer having a dialysate side and a blood side;

(b) providing a dry base concentrate comprising a citrate, bicarbonate and a salt, wherein a sodium contribution of the dry base concentrate to the dialysate ranges from 100 to 150 mEq/L and wherein ratio of bicarbonate (mEq/L) to citrate (mEq/L) in the dry base concentrate ranges from 50:1 to 15:8;

(c) providing an acid concentrate comprising an acid selected from the group consisting of acetic acid, citric acid and lactic acid, wherein (i) a sodium contribution of the acid concentrate to the dialysate ranges from 10 to 20 mEq/L, (ii) the combination of the sodium contributions of the dry base concentrate and the acid concentrate to the dialysate ranges from 125 to 150 mEq/L and (ii) the base concentrate and the acid concentrate are separated into separate containers;

(d) mixing said base concentrate, said acid concentrate, and water so as to produce dialysate;

(e) measuring conductivity of said dialysate with said conductivity sensor; and

(f) circulating said dialysate to said dialysate side of said dialyzer if said conductivity of said dialysis solution ranges from between about 12.5 and about 15.7 mS/cm and not circulating the dialysate if said conductivity falls outside of said conductivity range.

2. The method of claim 1 , wherein said citrate is selected from the group consisting of citric acid, a salt of citric anion, and a partial ester of citric anion.

3. The method of claim 1 , wherein said citrate is trisodium citrate, disodium hydrogen citrate or monosodium dihydrogen citrate.

4. The method of claim 3 , wherein the base concentrate is in a first vessel and the acid concentrate is in a second vessel, the first and second vessels containing an amount of said base and acid concentrates for preparation of a dialysate for treatment of a single patient.

5. The method of claim 1 , wherein said acid in said acid concentrate is acetic acid.

6. The method of claim 1 , wherein said salt is selected from the group consisting of sodium chloride, potassium chloride, calcium chloride and magnesium chloride.

7. The method of claim 1 , wherein said citrate is provided in a quantity to provide a final concentration in said dialysate from about 1 to about 8 mEq/L.

8. The method of claim 1 , wherein said bicarbonate is provided in a quantity to provide a final concentration in said dialysate from about 15 to about 50 mEq/L of said bicarbonate.

9. The method of claim 1 , wherein said salt is provided in a quantity to provide a final concentration in said dialysate from about 1.5 to about 150 mEq/L.

10. The method of claim 1 , wherein said acid in said acid concentrate being provided in a quantity sufficient to provide a final concentration in said dialysate of between about 1 to about 8 mEq/L.

11. The method of claim 1 , wherein the base concentrate comprises:

(a) sodium bicarbonate;

(b) sodium citrate, wherein molar ratio of sodium bicarbonate to sodium citrate ranges from 50:1 to 15:9; and

(c) sodium chloride in an amount sufficient to provide final concentration in the said dialysate of sodium in the range of 125 to 150 mEq/L when the base concentrate and acid concentrate are mixed with water.

12. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 36.5 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 127 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 88 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.

13. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 31.5 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 89 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.

14. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 36.5 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 84 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 2.5 mEq/L in the final dialysate.

15. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 35 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 127 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 88 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.

16. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 30.0 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 89 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.

17. The method of claim 1 , wherein the base concentrate comprises:

(a) bicarbonate in sufficient amount to provide about 35 mEq/L in the final dialysate;

(b) sodium in sufficient amount to provide about 123 mEq/L in the final dialysate;

(c) chloride in sufficient amount to provide about 84 mEq/L in the final dialysate; and

(d) citrate in sufficient amount to provide about 4 mEq/L in the final dialysate.

18. The method of claim 2 , wherein said citrate is citric acid and said citric acid is separated from said bicarbonate.

19. The method of claim 18 , wherein the base concentrate is contained in a vessel for preparation of a batch of dialysis solution for treatment of single patient and said salt is present as a layer deposited in the vessel between said citric acid and said bicarbonate.

20. The method of claim 18 , wherein said citric acid in the base concentrate is in the form of tablets.

21. The method of claim 20 , wherein the tablets are coated with dextrose and sodium chloride.

22. The method of claim 1 , wherein prior to step (c), the base concentrate and acid concentrate are separately dissolved into water to form aqueous base and acid concentrates.

23. The method of claim 22 , wherein the aqueous base and acid concentrates are metered to a metered volume of water so as to produce said dialysis solution on-line on a continuous basis.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074046/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074047/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2015
From: BAXTER HEALTHCARE SA, SINGAPORE BRANCH
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 036620/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2014
From: HHD, LLC
To: BAXTER HEALTHCARE SA, SINGAPORE BRANCH
Reel/Frame 032132/0209 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2007
From: AKSYS LTD., A DELAWARE CORPORATION
To: DURUS LIFE SCIENCES MASTER FUND, LTD., A CAYMEN ISLANDS EXEMPTED COMPANY
Reel/Frame 019466/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2007
From: DURUS LIFE SCIENCES MASTER FUND, LTD., A CAYMEN ISLANDS EXEMPTED COMPANY
To: HHD LLC, A DELAWARE LIMITED LIABILITY COMPANY
Reel/Frame 019466/0732 →
SECURITY AGREEMENT Recorded Apr 3, 2006
From: AKSYS, LTD., A DELAWARE CORPORATION
To: DURUS LIFE SCIENCES MASTER FUND, LTD., A CAYMEN ISLANDS EXEMPTED COMPANY
Reel/Frame 017400/0777 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 19, 2004
From: SHAH, DILIP H.; ING, TODD
To: AKSYS LTD.
Reel/Frame 015716/0071 →